Skip to main content
SpringerLink
Log in

Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurence of cholelithiasis

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The long-acting somatostatin analogue SMS 201-995 has been used efficaciously in the therapy of metastatic carcinoid tumor, vasoactive intestinal peptide producing islet cell carcinoma, acromegaly, and TSH secreting pituitary tumors. We report the development of a gallstone in a patient treated for 23 months with a long acting somatostatin analogue for a metastatic carcinoid tumor. Symptomatic improvement and a reduction in the urinary excretion of 5-hydroxyin-doleacetic acid occurred. There was no evidence of a gallstone on ultrasound and CT scan of the abdomen prior to somatostatin therapy. A progressively enlarging, asymptomatic gallstone developed during therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grahame Smith D.G. The carcinoid syndrome. In: De Groot L.J. (Ed.), Endocrinology. Grune & Stratton, Inc., New York, 1979, p. 1721.

    Google Scholar 

  2. Antonelli A., Del Guerra P., Fierabracci A., Gori E., Baschieri L. Effect of salmon calcitonin on symptoms and urinary excretion of 5 hydroxyindoleacetic acid in the carcinoid syndrome. Br. Med. J. 235: 961, 1987.

    Article  Google Scholar 

  3. Kvols L.K., Martin J.K., Marsh H.M., Moertel C.G. Rapid reversal of carcinoid crisis with a somatostatin analogue. N. Engl. J. Med. 373: 1229, 1985.

    Google Scholar 

  4. Kvols L.K., Moertel C.G., O’Connell M.J., Schutt A.J., Rubin J., Hahn R.G. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N. Engl. J. Med. 375: 663, 1986.

    Article  Google Scholar 

  5. Comi R.J., Gesundheit N., Murray L., Gorden P., Weintraub B.D. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N. Engl. J. Med. 317: 12, 1987.

    Article  CAS  PubMed  Google Scholar 

  6. Tauber J.P., Babin Th., Tauber M.T., Vigoni F., Bonafe A., Ducasse M., Harris A.G., Bayard F. Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. J. Clin. Endocrinol. Metab. 68: 917, 1989.

    Article  CAS  PubMed  Google Scholar 

  7. Moertel C.G. An odissey in the land of small tumors. J. Clin. Oncol. 5: 1503, 1987.

    Google Scholar 

  8. Lamberts S.W.J., Tilanus H.W., Klooswijk A.I.J., Banning H.A., Van der Lely A.J., De Jong F.H. Successfull treatment with SMS 201-995 of Cushing’s syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma. J. Clin. Endocrinol. Metab. 67: 1080, 1988.

    Article  CAS  PubMed  Google Scholar 

  9. Lamberts S.W.J. Clinical use of somatostatin analogues. Acta Endocrinol. (Copenh) 116 (Suppl. 286): 9, 1987.

    Google Scholar 

  10. Kraenzlin M.E., Ch’ing J.L.C., Wood S.M., Carr D.H., Bloom S.R. Long term treatment of a Vipoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 88: 185, 1985.

    Article  CAS  PubMed  Google Scholar 

  11. Reubi J.C. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumor growth. Acta Endocrinol. (Copenh) 109: 108, 1985.

    CAS  Google Scholar 

  12. Krenning E.P., Bakker W.H., Breeman W.A.P., Koper J.W., Kooij P.P.M., Ausema L., Lameris J.S., Reubi J.C., Lamberts S.W.J. Localisation of endocrine-related tumors with ra-dioiodinated analogue of somatostatin. Lancet 1: 4, 1989.

    Google Scholar 

  13. Sjoerdsma A. Clinical and laboratory features of malignant carcinoid. Arch. Inter. Med. 102: 936, 1958.

    Article  CAS  Google Scholar 

  14. Friesen H.R. Tumor of the endocrine pancreas. N. Engl. J. Med. 306: 580, 1982.

    Article  CAS  PubMed  Google Scholar 

  15. Van Liessum P.A., Hopman W.P.M., Pieters G.F.F.M., Jansen J.B.M.J., Smals A.G.H., Rosenbusch G., Kloppenborg P.W.C., Lamers C.B.H.W. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. J. Clin. Endocrinol. Metab. 69: 557, 1989.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Endocrinologia e Patologia Costituzionale Centro per lo Studio, Prevenzione, Diagnosi e Cura delle Tireopatie, Università degli Studi di Parma, Via Gramsci 14, Parma, 43100, Italy

    Elio Roti, R. Minelli, E. Gardini, M. Salvi & L. Bianconi

  2. Divisione di Chirurgia, Ospedale di Borgotaro, USL 6, I Clinica Chirurgica, Université degli Studi di Parma, Italy

    L. Balducci & A. Manfredi

  3. Division of Endocrinology and Metabolism, University of Massachusetts, Worcester, Mass, USA

    L. E. Braverman

Authors
  1. Elio Roti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Minelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Gardini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Salvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Bianconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Balducci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Manfredi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. E. Braverman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported in part by grant 85.00533.04,86.00134.04 and 88.00628.04 from Consiglio Nazionale delle Ricerche, Rome, by grant “Patologia delta Tiroide. Indagine dei Fattori Etiopatogenetici” of Ministero Pubblica Istruzione 40%, Rome, Italy, by grant DK-19819 from NIDDK, NIH, Bethesda, MD, and by NATO grant RG. 85/0696.

Dr. Eliana Gardini is a recipient of a fellowship from Associazione Volontaria Promozione Ricerca Tumori (A.VO.PRO.RI.T.), Parma, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roti, E., Minelli, R., Gardini, E. et al. Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurence of cholelithiasis. J Endocrinol Invest 13, 69–72 (1990). https://doi.org/10.1007/BF03348589

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348589

Key-words

Search

Navigation